Physician profile
Jose Cura, JR.
NPI 1629059167
$2,792.06
in general payments reported to CMS, 2019-2025
26 companies · $544 in 2025
The $544 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $86.78 · 2021: $29.07 · 2022: $664 · 2023: $638 · 2024: $398 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $392.11 | 2019-2025 | |
| Pfizer INC. | $285.46 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $259.80 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $223.51 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.36 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $197.02 | 2019-2025 | Lifevest |
| Amgen INC. | $184.91 | 2019-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $176.74 | 2022-2024 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $146.52 | 2022-2023 | |
| Boston Scientific Corporation | $92.87 | 2023-2025 | Watchman Access System, Watchman Flx |
| Medtronic, INC. | $82.46 | 2023-2025 | Micra, Linq II, Attain Command + Surevalve |
| Merck Sharp & Dohme LLC | $55.18 | 2022-2025 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $51.96 | 2019 | |
| Janssen Pharmaceuticals, INC | $51.54 | 2019-2022 | |
| Biotronik INC. | $46.74 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $44.91 | 2022-2025 | |
| Amarin Pharma, INC. | $43.05 | 2019-2020 | |
| Novo Nordisk INC | $41.27 | 2025 | Wegovy |
| Abbott Laboratories | $39.19 | 2022-2024 | Cardiomems |
| Portola Pharmaceuticals, LLC | $37.52 | 2019 | |
| Philips North America LLC | $33.59 | 2023-2025 | Lm Undivided |
| Procyrion, INC. | $30.71 | 2025 | Aortix System |
| Siemens Medical Solutions USA, INC. | $21.42 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $21.33 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $15.71 | 2023 | |
| Cvrx, INC. | $7.18 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Cura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.